- 专利标题： TRICYCLIC COMPOUND AS CRTH2 INHIBITOR
-
申请号： EP17830501.7申请日： 2017-07-21
-
公开(公告)号： EP3489235A1公开(公告)日： 2019-05-29
- 发明人: CHEN, Bin , YAO, Yuanshan , CHEN, Yuan , LI, Ao , XU, Ran , HUANG, Zhensheng , TIAN, Dongdong , LI, Hongwei , YANG, Chengshuai , LI, Jian , CHEN, Shuhui
- 申请人： Chia Tai Tianqing Pharmaceutical Group Co., Ltd. , Medshine Discovery Inc.
- 申请人地址： No. 369 Yuzhou South Road Lianyungang, Jiangsu 222062 CN
- 专利权人： Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Medshine Discovery Inc.
- 当前专利权人： Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Medshine Discovery Inc.
- 当前专利权人地址： No. 369 Yuzhou South Road Lianyungang, Jiangsu 222062 CN
- 代理机构： Elsy, David
- 优先权： CN201610581810 20160721
- 国际公布： WO2018014867 20180125
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D487/04 ; A61K31/4985 ; A61K31/437 ; A61K31/4709 ; A61K31/444 ; A61P43/00
摘要：
Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors.
信息查询
